
Neuregulin-1 (NRG-1) exerts biological functions by interacting with ErbB receptors. Action and dysregulation of NRG-1 are closely related to neurodegenerative disorders, including Alzheimer's disease and cardiovascular diseases (Bartus et al., 2016; Kang et al., 2019; Kang et al., 2020; Vrillon et al., 2022). Inflammation results in an increase in cytokine secretion and neutrophil survival, resulting in the exacerbation of allergic disorders, including asthma, allergic rhinitis and atopic dermatitis (Holgate, 2008; Kim et al., 2014; Kim et al., 2020; Lee, 2020). IL-6, IL-8, and MCP are inflammation-related cytokines that regulate the survival rate of neutrophils by reducing their apoptosis. In this study, the treatment with TNF-α and IFN-γ was used as inflammatory activators, and human lung epithelial BEAS-2B cells were used as cytokine secreting cells.
First, the effect of NRG-1 on the secretion of IL-6, IL-8, and MCP-1 in BEAS-2B cells was examined. Although NRG-1 alone had no effect on the release of IL-6, IL-8, and MCP-1, co-treatment of TNF-α and IFN-γ with NRG-1 suppressed the secretion of these cytokines enhanced by TNF-α and IFN-γ (Fig. 1). These results indicate that NRG-1 acts as an essential regulator in cytokine expression in an inflammatory state. The study also examined whether the decreased level of cytokines by NRG-1 treatment, such as IL-6, IL-8, and MCP-1, affects the apoptosis of neutrophils and eosinophils. As shown in Fig. 2A, TNF-α and IFN-γ doesn't block eosinophil apoptosis but neutrophil apoptosis. Single NRG-1 had no effect on neutrophil and eosinophil apoptosis. Co-treatment of TNF-α and IFN-γ with NRG-1 did not affect the inhibition of neutrophil apoptosis due to TNF-α and IFN-γ. The supernatant collected from the BEAS-2B cells after treatment with TNF-α and IFN-γ inhibited neutrophil apoptosis (Fig. 2B). However, the supernatant of BEAS-2B cells after co-treatment of TNF-α and IFN-γ with NRG-1 showed a decreased anti-apoptotic effect on neutrophils compared to the effect of the supernatant stimulated with TNF-α and IFN-γ. It has been reported that NRG-1 enhances MUC5AC and MUC5B expression in human bronchial epithelial cells (HBECs) and may result in the aggravation of allergy (Kettle et al., 2010). In contrast to this finding, NRG-1 exhibits a protective role by its anti-inflammatory and anti-oxidative effects on cardiocytes by regulating IL-1, IL-6, IL-8, and IL-10 (Kang et al., 2019). Our results show that NRG-1 by itself has no effect on cytokine secretion and apoptosis in BEAE-2B cells and neutrophils, respectively.
In an inflammatory state, NRG-1 exhibits a protective effect that reduces IL-6, IL-8, and MCP-1, which connects with the reversal of neutrophil apoptosis decreased by TNF-α and IFN-γ. Previous studies have reported the close relation of allergy with cytokine secretion and neutrophil apoptosis (Hong et al., 2021; Jeon et al., 2021). Based on these findings, NRG-1 may play a critical role in the protection of exacerbations of allergies as well as other inflammatory diseases. This study has limitations with respect to the number of normal subjects and the absence of subjects suffering from specific inflammatory diseases. Hence, further studies are required to unveil the clear mechanism of the anti-inflammatory action induced by NRG-1 in specific inflammatory diseases.
This paper was supported by Wonkwang Health Science University in 2022.
The authors have no conflicts of interest, financial or otherwise, to declare.